4//SEC Filing
Bermingham Nessan 4
Accession 0001209191-20-060342
CIK 0001566373other
Filed
Nov 23, 7:00 PM ET
Accepted
Nov 24, 6:56 PM ET
Size
8.6 KB
Accession
0001209191-20-060342
Insider Transaction Report
Form 4
Bermingham Nessan
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-20+34,111→ 34,111 totalExercise: $16.62Exp: 2028-04-01→ Common Stock (34,111 underlying) - Award
Restricted Stock Units
2020-11-20+16,875→ 16,875 total→ Common Stock (16,875 underlying)
Footnotes (4)
- [F1]This option was issued in replacement of an option to purchase shares of F-star Therapeutics Limited.
- [F2]So long as Participant remains continuously a Service Provider 28% of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, April 1, 2018, and 2% of the total number of Shares under Award shall vest monthly thereafter.
- [F3]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F4]Twenty-five per cent (25%) of the total number of Shares under Award shall vest on the first anniversary of the Vesting Commencement Date, July 1, 2020, and two and one twelfth per cent (2.083%) of the total number of Shares under Award shall vest monthly thereafter, provided in each case that the Participant remains a Service Provider continuously from the Vesting Commencement Date to the relevant date.
Documents
Issuer
F-star Therapeutics, Inc.
CIK 0001566373
Entity typeother
Related Parties
1- filerCIK 0001377759
Filing Metadata
- Form type
- 4
- Filed
- Nov 23, 7:00 PM ET
- Accepted
- Nov 24, 6:56 PM ET
- Size
- 8.6 KB